Venture Financing Arrangements in the North American Medical Device Industry

0

According to GlobalData’s deal database, medical device industry total risk financing deals worth $1.2 billion were announced in North America in January 2022, led by financing at risk of $215 million for Enable Injections.

  • Embed this graphic

    Embed this graphic in your website

    Copy and paste the image source into your website to view the graphic.

The value marked a 26% drop from the prior month of $1.58 billion and a 21% drop from the trailing 12-month average of $1.48 billion.

North America held a 50.21% share of the global medical device industry’s venture finance deal value which amounted to $2.33 billion in January 2022. With a share of 50 .21% and deals worth $1.17 billion, the United States was the top country in North America for the value of venture financing deals across the medical device industry.

In terms of venture funding activity, North America saw 57 deals in January 2022, marking a 32.14% decline from the previous month and a 24.00% decline from the average over 12 months. The United States recorded 54 transactions during the month.

Content from our partners
The importance of validated cleanrooms in the assembly of medical devices
How innovative ventilation helped a 258-gram baby defy the odds

Medical Device Industry Venture Financing Deals in North America in January 2022: Best Deals

The medical device industry’s top five venture finance deals accounted for 61.6% of overall value in January 2022.

The combined value of the top five medical device venture financing deals was $722 million, compared to the aggregate value of $1.2 billion recorded for the month.

The top five medical device industry venture finance deals of January 2022 tracked by GlobalData were:

1) Cincinnati Children’s Hospital Medical Center, CincyTech, Cintrifuse Syndicate Fund, GCM Grosvenor, Magnetar Capital, Ohio Innovation Fund, Squarepoint Capital and Woody Creek Capital Partners $215 million funding agreement with Enable Injections

2) Iterative Scopes $150M Venture Funding by Breyer Capital, Clearlake Capital Group, Eli Lilly and Co, Insight Partners, JJDC and Obvious Ventures

3) Coatue, CRV, Lightspeed Venture Partners – USA, Salesforce Ventures, Silverton Partners, Tiger Global Management and Tusk Venture Partners $150M funding deal with Wheel Health

4) The $132 million venture financing of Athelas by General Catalyst Partners, Greenoaks Capital Management, Human Capital Investment Management, Initialized Capital, Sequoia Capital Operations, Tribe Capital and Y Combinator

5) ArrowMark Partners, Gilde Healthcare Partners, Kaiser Permanente Ventures, Morningside Ventures, Octopus Ventures and SoftBank Vision Fund 2 $75M venture funding deal with Big Health

Related companies

Share.

About Author

Comments are closed.